Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer
Clinical trial NCT02899728 · TERMINATED
Trial details
- NCT number
- NCT02899728
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-30
- Primary completion
- 2020-03-17
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.